Ifrah Financial Services’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-44,232
Closed -$121K 206
2017
Q4
$121K Buy
44,232
+647
+1% +$1.99K 0.04% 193
2017
Q3
$148K Buy
43,585
+313
+0.7% +$870 0.06% 188
2017
Q2
$107K Sell
43,272
-692
-2% -$1.59K 0.04% 181
2017
Q1
$100K Sell
43,964
-1,347
-3% -$2.98K 0.04% 183
2016
Q4
$96K Sell
45,311
-2,287
-5% -$6.38K 0.04% 186
2016
Q3
$159K Buy
47,598
+13,955
+41% +$44.3K 0.06% 185
2016
Q2
$106K Buy
33,643
+1,107
+3% +$3.69K 0.04% 192
2016
Q1
$108K Buy
32,536
+2,106
+7% +$6.57K 0.04% 189
2015
Q4
$108K Sell
30,430
-3,794
-11% -$15.9K 0.04% 185
2015
Q3
$172K Buy
34,224
+339
+1% +$1.94K 0.07% 184
2015
Q2
$218K Buy
33,885
+62
+0.2% +$415 0.08% 182
2015
Q1
$238K Buy
33,823
+479
+1% +$3.47K 0.09% 178
2014
Q4
$257K Sell
33,344
-912
-3% -$7.22K 0.1% 162
2014
Q3
$256K Buy
34,256
+2,954
+9% +$27.4K 0.1% 159
2014
Q2
$303K Buy
31,302
+458
+1% +$4.08K 0.11% 139
2014
Q1
$256K Buy
+30,844
New +$264K 0.1% 162

Other funds holding PDLI